0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From the JAMA Network | 
Ronald Klein, MD, MPH; Barbara E. K. Klein, MD, MPH
JAMA. 2016;315(16):1778-1779. doi:10.1001/jama.2016.3849.

JAMA Clinical Challenge | 
Wenyu Huang, MD, PhD; Rukhsana G. Mirza, MD; Mark E. Molitch, MD
JAMA. 2015;314(23):2555-2556. doi:10.1001/jama.2015.9162.

Editorial | 
Timothy W. Olsen, MD
JAMA. 2015;314(20):2135-2136. doi:10.1001/jama.2015.15409.

Original Investigation |  FREE
Writing Committee for the Diabetic Retinopathy Clinical Research Network
JAMA. 2015;314(20):2137-2146. doi:10.1001/jama.2015.15217.
Includes: CME, Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(20):2184-2185. doi:10.1001/jama.2015.15427.

From the JAMA Network | 
Sandeep Vijan, MD, MS; Angela Fagerlin, PhD
JAMA. 2015;314(17):1861-1862. doi:10.1001/jama.2015.11518.

From the JAMA Network | 
Kurt Kroenke, MD
JAMA. 2015;313(16):1666-1667. doi:10.1001/jama.2015.107.

Editorial | 
Bryan Williams, MD
JAMA. 2015;313(6):573-574. doi:10.1001/jama.2015.89.

Original Investigation |  FREE
Connor A. Emdin, HBSc; Kazem Rahimi, DM, MSc; Bruce Neal, PhD; et al.
JAMA. 2015;313(6):603-615. doi:10.1001/jama.2014.18574.
Includes: CME, Supplemental Content

Viewpoint | 
Lee M. Jampol, MD; Neil M. Bressler, MD; Adam R. Glassman, MS
JAMA. 2014;311(22):2269-2270. doi:10.1001/jama.2014.2536.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L. Ross, BA; David W. Hutton, PhD; Joshua D. Stein, MD, MS; et al.
JAMA Ophthalmology
JAMA Ophthalmology Clinical Challenge  | 
An Unexpected Postvitrectomy Course
Aristomenis Thanos, MD; Bobeck S. Modjtahedi, MD; Dean Eliott, MD
JAMA Ophthalmology
Original Investigation  | 
Select Features of Diabetic Retinopathy on Swept-Source Optical Coherence Tomographic Angiography Compared With Fluorescein Angiography and Normal Eyes
David A. Salz, MD; Talisa E. de Carlo, BA; Mehreen Adhi, MD; et al.
JAMA Ophthalmology
Invited Commentary  | 
Driving Eligibility in Proliferative Diabetic Retinopathy
Cynthia Owsley, PhD, MSPH; Gerald McGwin Jr, MS, PhD